Cargando…

Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence

The role of testosterone in the pathophysiology of inflammation is of critical clinical importance; however, no universal mechanism(s) has been advanced to explain the complex and interwoven pathways of androgens in the attenuation of the inflammatory processes. PubMed and EMBASE searches were perfo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Traish, Abdulmaged, Bolanos, Jose, Nair, Sunil, Saad, Farid, Morgentaler, Abraham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306858/ https://www.ncbi.nlm.nih.gov/pubmed/30558178 http://dx.doi.org/10.3390/jcm7120549

Ejemplares similares

Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
por: Morgentaler, Abraham, et al.
Publicado: (2020)

Recognizing the True Value of Testosterone Therapy in Health Care
por: Morgentaler, Abraham, et al.
Publicado: (2022)

Androgens Modulate Endothelial Function and Endothelial Progenitor Cells in Erectile Physiology
por: Traish, Abdulmaged M., et al.
Publicado: (2013)

Obesity and Erectile Dysfunction: Is Androgen Deficiency the Common Link?
por: Feeley, Robert J., et al.
Publicado: (2009)

Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth
por: Traish, A M, et al.
Publicado: (2009)

Testosterone and weight loss: the evidence
por: Traish, Abdulmaged M.
Publicado: (2014)

Rapidly Shifting Concepts Regarding Androgens and Prostate Cancer
por: Morgentaler, Abraham
Publicado: (2009)

MON-091 Profound and Sustained Weight Loss in Men With Hypogonadism and Obesity Receiving Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

SAT-533 Men with Hypogonadism and Osteoporosis Benefit from Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU) Regardless of Co-Medication with Bisphosphonates: 10-Year Data from a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

OR21-2 Lipid Profiles Improve in Men With Hypogonadism and Pre-existing Cardiovascular Disease Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): 10-year Data From a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

SUN-083 Hypertension and Hemodynamic Parameters in Men with Hypogonadism Improve Under Long-Term Treatment with Testosterone Undecanoate Injections (TU) Compared to Untreated Hypogonadal Control Patients
por: Saad, Farid, et al.
Publicado: (2019)

SUN-226 Improvements In Quality Of Life In Men With Hypogonadism Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): Experience From 6,500 Patient-years Ina Registry Study Ina Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

SUN-055 Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism Treated with Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Saad, Farid, et al.
Publicado: (2019)

Erratum: Correction of the references for Figures. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
por: Traish, Abdulmaged
Publicado: (2017)

Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
por: Traish, Abdulmaged
Publicado: (2016)

Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups
por: Traish, Abdulmaged M., et al.
Publicado: (2017)

Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm
por: Traish, Abdulmaged M.
Publicado: (2020)

Sex steroids and COVID-19 mortality in women
por: Traish, Abdulmaged M.
Publicado: (2021)

Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years
por: Haider, Ahmad, et al.
Publicado: (2014)

Successful treatment of Post-orgasmic illness syndrome with human chorionic gonadotropin
por: Bolanos, Jose, et al.
Publicado: (2019)

Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome
por: Traish, Abdulmaged M., et al.
Publicado: (2018)

Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study
por: Haider, Karim Sultan, et al.
Publicado: (2020)

The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
por: Traish, Abdulmaged M., et al.
Publicado: (2014)

SUN-222 Testosterone Treatment in Men with Classical vs. Functional Hypogonadism: A 9-Year Registry
por: Zitzmann, Michael, et al.
Publicado: (2019)

Rotational Atherectomy: A Contemporary Appraisal
por: Gupta, Tanush, et al.
Publicado: (2019)

International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
por: Parish, Sharon J., et al.
Publicado: (2021)

Contemporary functional neuroanatomy and pathophysiology of dystonia
por: Brüggemann, Norbert
Publicado: (2021)

Appraisal of the Deqi Concept among Contemporary Chinese Acupuncturists
por: Chen, Sheng, et al.
Publicado: (2013)

Oral Tofacitinib: Contemporary Appraisal of Its Role in Dermatology
por: Sonthalia, Sidharth, et al.
Publicado: (2019)

Examining Male Predominance of Severe COVID-19 Outcomes: A Systematic Review
por: Twitchell, David K., et al.
Publicado: (2022)

Testosterone deficiency and cardiovascular mortality
por: Morgentaler, Abraham
Publicado: (2015)

Nerve growth factor as a new treatment for testosterone deficiency?
por: Morgentaler, Abraham
Publicado: (2018)

Streptozotocin-induced diabetes in the rat is associated with changes in vaginal hemodynamics, morphology and biochemical markers
por: Kim, Noel N, et al.
Publicado: (2006)

Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat
por: Kim, Noel N, et al.
Publicado: (2006)

Immunodetection of nmt55/p54(nrb) isoforms in human breast cancer
por: Pavao, Matthew, et al.
Publicado: (2001)

Pathophysiological effects of androgens on the female vascular system
por: Stone, Tori, et al.
Publicado: (2020)

The Bologna criteria for poor ovarian response: a contemporary critical appraisal
por: Younis, Johnny S., et al.
Publicado: (2015)

A Critical Appraisal of Contemporary and Novel Biomarkers in Pheochromocytomas and Adrenocortical Tumors
por: Tsoli, Marina, et al.
Publicado: (2021)

Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management
por: Baruteau, Alban-Elouen, et al.
Publicado: (2016)

Major Pathophysiological Correlations of Rosacea: A Complete Clinical Appraisal
por: Vemuri, Ravi Chandra, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ghfbj52ent272mki0gl93eq5rh